Keywords: ambulatory blood pressure; clinic blood pressure; carotid atherosclerosis; left ventricular hypertrophy Clinic blood pressure (BP) measurements have long been the mainstay of hypertension diagnosis and management. There is a wealth of epidemiological evidence linking elevated clinic BP readings with cardiovascular morbidity and mortality. Reduction of clinic pressures does reduce cardiovascular deaths. While many cross-sectional studies have shown superior associations between ambulatory BP (ABP) and target organ damage than between clinic BP (CBP) and organ damage, there is a relative lack of longitudinal data assessing the predictive value of ambulatory pressures for cardiovascular damage and hard end-points. A study performed by Perloff and colleagues in 1983 suggests that daytime ABP predicts excess cardiovascular morbidity and mortality independently of CBP.
Clinic blood pressure (BP) measurements have long been the mainstay of hypertension diagnosis and management. There is a wealth of epidemiological evidence linking elevated clinic BP readings with cardiovascular morbidity and mortality. Reduction of clinic pressures does reduce cardiovascular deaths. While many cross-sectional studies have shown superior associations between ambulatory BP (ABP) and target organ damage than between clinic BP (CBP) and organ damage, there is a relative lack of longitudinal data assessing the predictive value of ambulatory pressures for cardiovascular damage and hard end-points. A study performed by Perloff and colleagues in 1983 suggests that daytime ABP predicts excess cardiovascular morbidity and mortality independently of CBP. 1 Ongoing trials, such as the OvA Study (Office versus Ambulatory blood pressure study), the 24-h ABP sub-study of Syst-Eur, and the SAMPLE Study (Study in Ambulatory Monitoring of blood Pressure and Lisinopril Evaluation), will provide clear answers on whether fatal and non-fatal cardiovascular events are better predicted by office BP (OBP) or ABP, and on whether management of hypertensive patients should be guided by CBP or by ABP. Meanwhile, published in this issue of Journal of Human Hypertension is a paper which examines whether current measures of carotid atherosclerosis and left ventricular hypertrophy are better predicted by previous measures of OBP or ABP. interval ± s.d.) prior to the follow-up visit at which echocardiography and carotid ultrasonogrpahy were performed. Medical history, physical examination, risk factor profile, and serum cholesterol were also assessed at follow-up. The principle findings of the study were as follows; age, 24-h mean systolic BP and body mass index were independent correlates of left ventricular hypertrophy, whereas age, 24-h mean pulse pressure and cigarette pack years were independent predictors of carotid atherosclerosis. CBP did not feature in the final model for the long term prediction of cardiovascular end-organ damage.
Khattar and colleagues concluded that as ABP correlated better than OBP, with both left ventricular hypertrophy and carotid atherosclerosis, their 'findings promoted a role for ambulatory BP monitoring in guiding aggressiveness of drug therapy in an attempt to limit potential target organ damage.' Substantial increases in usage of ambulatory BP monitoring would be the inevitable consequence of acceptance of this advice-this would have considerable consequences for health resources. There is obviously a requirement to evaluate the validity of the authors conclusions.
In the absence of hard end-points-morbidity and mortality data-the study used two well recognised cardiovascular surrogate end-points.
Echocardiographic left ventricular hypertrophy is a strong independent predictor of morbidity and mortality. 3 We know that regression of left ventricular hypertrophy can be achieved with BP reduction. 4, 5 Framingham subjects with a reduction in ECG voltage (signifying a reduction in left ventricular hypertrophy) during long-term follow up fared better than those without a reduction in ECG voltage. 6 Unfortunately, to date, no adequately powered study has assessed the prognostic value of regression versus progression of echocardiographic left ventricular hypertrophy.
Carotid intima media thickness (IMT) is a relatively new surrogate measure of cardiovascular target organ damage. High resolution B-mode ultrasonography allows non-invasive visualisation of the walls of large superfical arteries. Early atherosclerosis, non-occluding plaques and thickening of the intima media layers may be seen with ease. Increased IMT and plaque in the common carotid artery have been associated with a wide spectrum of cardiovascular risk factors, including age, male sex, race, hypertension, hyperlipidaemia, smoking, diabetes mellitus, left ventricular hypertrophy, plasma homocysteine, uric acid, and fibrinogen. 7 A number of prospective studies have shown that increased carotid IMT predicts risk of myocardial infarction 8 and stroke. 9 Blood pressure reduction and lipid-lowering therapies have been shown to retard progression of common carotid IMT. 10, 11 While overall the Northwick Park study 2 was a large and carefully executed study which addressed an important issue, I have some concerns about potential biases or errors that may have contributed to the end results.
A very select group of hypertensive patients were studied-only patients referred to this specialist hypertension clinic, with sustained office hypertension, without overt cardiovascular disease, and who agreed to intra-arterial ambulatory BP monitoring (IABPM) were included. There was considerable loss of patients at every step along the path. Originally a total of 723 hypertensive patients underwent IABPM, but only 295 patients were included in the final analysis. Ninety-six died in the interval between BP assessment and follow-up. Two hundred and twenty-six did not return for followup. Eighty-three patients had developed symptomatic cardiovascular disease by follow-up, and 23 patients did not have technically adequate scans. No CBP nor ABP data were given for these excluded patients. With approximately 60% loss from the original cohort, confounding is certainly possible.
Stepwise logistic regression analysis was performed to determine the independent predictors of left ventricular hypertrophy and intima media thickness. The variables that were assessed in the multivariate analysis were age, gender, body mass index, serum cholesterol, pack years of smoking and BP data. There were 75 non-Caucasians in the sample, and diabetes was not an exclusion factor. Ethnic group and diabetes are known to be associated with both hypertension and organ damage. The variables do not appear to have been included in the model, and hence may have influenced the end result. The influence of different classes of antihypertensive therapy over the 10 years was also not addressed.
There are many established methods for quantifying IMT. Both distal common carotid IMT and maximum IMT in the carotid arterial tree have been used by various researchers, and both appear to correlate with cardiovascular risk factors and atherosclerotic disease and events. [7] [8] [9] In this study, the common carotid, bulb and proximal internal and external carotid arteries were assessed for presence of plaque. Where plaque was present, maximal IMT was measured at that site (IMT max ). In the absence of plaque, IMT of the far wall of the distal common carotid was taken as IMT max . Hence IMT max was measured by distinctly different methods in those with and without atherosclerotic plaques. It appears highly unlikely that the distribution of IMT max was normal, and therefore non-parametric statistical analyses possibly should have been utilised.
A final comment! Patients with left ventricular hypertrophy and atheroma had significantly higher CBP and ABP levels at baseline than patients without cardiac hypertrophy or plaques. It is noteworthy that CBP reductions from baseline to follow-up in those with LVH and those without LVH (11/10 and 16/9), and in those with and without atherosclerosis (15/12 and 14/7) were very similar. Hence those patients identified as being at greatest risk by both CBP and ABP did not have their BP more aggressively reduced. Currently there is widespread undertreatment of hypertension. The results of this study are consistent with the frequently quoted 'rule of halves'. On average half of hypertension cases are detected; half of these are treated; and half of these are well controlled. It appears that performance of IABPM, an invasive procedure, in the 295 patients described in this study, did not result in better BP control. Khattar and colleagues advocate a greater role for ambulatory BP monitoring in guiding aggressiveness of drug therapy aiming to reduce the risk of future cardiovascular complications. Benefits to patients will only accrue if identification of excess risk is followed by effective therapeutic intervention.
